Cryoglobulins can accompany another condition or be an seclude condition themselves, called cryoglobulinemia. Cryoglobulinemia connected with a specific disease (lymphoproliferative disorder, autoimmune disease, infectious disease) is known as secondary cryoglobulinemia.

Cryoglobulinemia without an associated disease has been named as essential, or idiopathic, cryoglobulinemia. Cryoglobulins in the blood (cryoglobulinemia) can cause conditions all in the body. Cryoglobulinemia may be characterised on basis of cryoglobulin composition with the Brouet classification. Type I cryoglobulinemia, and Types II and III cryoglobulinemia (mixed cryoglobulinemia) have rheumatoid factors (RFs).

Common symptom of mixed cryoglobulinemia (MC) is purpura, which is a purple sullied rash caused by internal bleeding. Cryoglobulins in the blood (cryoglobulinemia) may cause conditions around the body. The most primary objective of any treatment regimen for MC is elimination of the HCV infection.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may be applied in patients with symptoms of arthralgia and fatigue. Steroids are dictated for more serious symptoms such as sensory neuropathy and glomerulonephritis. A low-antigen gratified diet has also shown promise for treatment of liver disease. Immunosuppressive medications are indicated upon warrant of organ involvement such as vasculitis.

Plasmapheresis (hemapheresis), a method whereby the blood’s serum is replaced with saline (salt water), is also performed for severe symptoms. Anti-CD20 chimeric monoclonal antibody rituximab is effective in managing disease manifestations such as vasculitis, peripheral neuropathy, arthralgias, low-grade B-cell lymphomas, and fever.

Life threatening conditions, like acute progressive glomerulonephritis, motor neuropathy, and hyperviscosity syndrome, are treated with plasma exchange therapy accompanied by immunosuppressive drugs. Cryoglobulinemia is treated absolutely with suppression of the immune response.

Cryoglobulinemia Mixed - Prevention and Treatment Tips

1. Nonsteroidal anti-inflammatory drugs (NSAIDs) can be implemented in patients with symptoms of arthralgia and fatigue.

2. Steroids are prescribed for more serious symptoms such as sensory neuropathy and glomerulonephritis.

3. A low-antigen content diet has also shown promise for treatment of liver disease.

4. Anti-CD20 chimeric monoclonal antibody rituximab is effective in controlling disease manifestations such as vasculitis.

5. Azathioprine is commonly used as a steroid-sparing agent, and chlorambucil has also been used for severe vasculitis.

6. Cryoglobulinemia is treated simply with suppression of the immune response.